Staley Capital Advisers Inc
- SEC CIK
- 0001106565
- Latest filing
- Aug 11, 2026
MLTX holding history
MoonLake Immunotherapeutics in every 13F filed by Staley Capital Advisers Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MLTX overviewAll 13F holders of MLTXFull Q2 2026 holdings
- Shares (Q2 2022)
- 0
- Sold out in Q2 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2022 | 0 | $0 | 0.0% | −580,000−100.0% | Sold out | Holders |
| Q1 2022 | 580,000 | $6.35M | 0.3% | 00.0% | Unchanged | Holders |
| Q4 2021 | 580,000 | $5.74M | 0.3% | 00.0% | Unchanged | Holders |
| Q3 2021 | 580,000 | $5.71M | 0.3% | +80,000+16.0% | Added | Holders |
| Q2 2021 | 500,000 | $5.17M | 0.3% | +200,000+66.7% | Added | Holders |
| Q1 2021 | 300,000 | $3.06M | 0.2% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.